In July 2011, we wrote again. This time, we presented them with the 2011 Hepatitis Strategy Report Card along with an executive summary. The purpose of the report card (which we update on an on-going basis) was to highlight the successes and record the gaps in provincial, territorial and federal strategies towards a coordinated national approach to address hepatitis B and C. The data gathered reinforced our belief that a fully-funded, coordinated national strategy was more urgent than ever.

Over the last year, members of the coalition have continued to work with the federal, provincial and territorial governments to reduce new infections, deaths and suffering caused by the hepatitis B and C viruses. While we recognize and applaud the progress that has been made at various levels in many parts of the country, monitoring of government responses to our initial national Six Asks indicates that there remains much to be achieved as we approach the original 2012 deadline.

In looking at the present national situation, three priority areas have been identified for which we ask that concrete measures be implemented before the end of 2012. These priority areas are:

1) Increasing awareness and preventing hepatitis B and hepatitis C infections among at-risk populations.

2) Improving access to health care and drug coverage.

3) Supporting communities and groups through stable funding for prevention, education, care and support.

While new, very effective drugs have been developed such as boceprevir and telaprevir, they are not yet available to all Canadians who desperately need them. In the United States, the Centres for Disease Control and Prevention (CDC) urges people born between 1945 and 1965 to be tested, noting that roughly 75% of people with the disease are baby boomers. Canada has no plans to follow the lead of the U.S. and urge all baby boomers to be tested. The Public Health Agency of Canada is currently reviewing its options, and a report is to be completed by March 2013 that “will help shape our future hep C screening guidelines.” Canada should not drag its feet. Our baby boomers are no less at risk.

The Coalition produced a Briefing Note: Hepatitis B & Hepatitis C which provides a snapshot of the burden of hepatitis B and hepatitis C and the socio-economic costs in Canada. Effective medicines and control strategies are available to dramatically reduce suffering and deaths caused by these diseases and yet federal, provincial and territorial governments have not put forth concerted efforts to fight hepatitis B and C by providing adequate funding and national policy to ensure success.

There are many factors that contribute to the burdens of hepatitis B and C, and those living with and affected by hepatitis B and C not only suffer from the disease but also stigmatization, shame and anguish. The magnitude of impact on human lives and to society can be minimized and / or avoided at lower costs with the correct management strategies initiated today. Healthy outcomes for individuals can be achieved as well as solutions to the key determinants through enhanced cross-sectorial collaborations, increased funding and prioritized spending.

In a July 2012 letter, we are asking our elected government officials to provide leadership in addressing the issues and gaps identified in the Coalition’s Briefing Note and strengthen the delivery of hepatitis C and hepatitis B healthcare to reach the entire population, particularly the most vulnerable and difficult-to-reach. Through collaborations, implementation of solutions in a solid national strategy we have the ability to save lives, improve the quality of lives and limit the impact of hepatitis B and hepatitis C in Canada. The Canadian Coalition of Organizations Responding to Hepatitis B and C awaits an update on the status of our government’s strategies to respond to the three priority areas listed above and looks forward to working with F/P/T governments towards this end.

We hope that our elected officials will use the July 28 2012 World Hepatitis Day to make meaningful announcements to this end and that they will add this subject to the agenda of the next Conference of Ministers of Health  which we understand should be taking place in the Fall of 2012.

For each of the 6 Asks, a number of ‘issues’ were developed, each accompanied by a series of expectations for how the Coalition defines success in addressing the issue. Further, for each expectation, a measurement was identified to indicate whether the expectation is being met. The activities of each province and territory, as well as the federal government, were explored and documented over a period of approximately five months. Input was sought from key stakeholders in each region, including health authorities, government officials, and community organizations. The data gathered reinforces our belief that a coordinated national strategy is more urgent than ever.

We are asking our governments to take a leadership role in creating a national strategy that by 2012 will address the issues and gaps identified in the 2011 Hepatitis Strategy Report Card as contributing to the suffering of so many Canadians. We look forward to working towards this end with our elected representatives.

In acknowledging World Hepatitis Day (WHD), July 28, members of the Canadian Coalition of Organizations Responding to Hepatitis B and C reflect the call by the World Hepatitis Alliance and the World Health Organization (WHO) for coordinated efforts in all countries to ensure that viral hepatitis prevention, treatment and support is addressed.

The Coalition is continuing its efforts to bring increased attention to the response to hepatitis B and C in Canada.

Please consider joining our efforts and contributing your ideas, thoughts and actions to the cause.

You can join by filling out the membership form and sending it in to us at canadahepbccoalition@gmail.com.

Stay tuned for more updates for the Canadian Coalition of Organizations Responding to Hepatitis B and C!

• A fully-funded coordinated National Hepatitis B and C Strategy through endorsement of the Canadian Six Asks by 2012

HOW:

PHONE, MEET WITH OR SEND A LETTER OR E-MAIL TO YOUR FEDERAL AND PROVINCIAL/TERRITORIAL PARTY LEADERS, THE PRIME MINISTER, YOUR PREMIER, THE MINISTERS OF HEALTH AND YOUR LOCAL MP AND MLA TO LET THEM KNOW THAT YOU SUPPORT THE ADOPTION OF THE SIX CANADIAN ASKS ENDORSING A FULLY-FUNDED, COORDINATED NATIONAL STRATEGY FOR BOTH HEPATITIS B AND C BY 2012 THAT:

1. Promotes prevention of hepatitis B and C through expanded education, immunization and harm reduction programs all across Canada.
2. Improves access to comprehensive care and treatment programs in all areas of the country.
3. Increases knowledge and innovation through interdisciplinary research and surveillance to reduce the burden of hepatitis B and C on Canadians.
4. Creates awareness about risk factors, stigma and the need for testing among the general population and at-risk groups.
5. Builds capacity through training and recruitment of qualified health professionals.
6. Supports communities and community-based groups in developing, delivering and evaluating peer-driven and focused initiatives.

WHY NOW?

More than enough people have died from both hepatitis B and C, diseases that are preventable and treatable. Given that the Sixty-third World Health Assembly recently adopted an important resolution about viral hepatitis, Canada now needs to act by adopting a coordinated comprehensive national strategy to address the epidemic which exists in Canada.

PARTICIPATE IN THIS IMPORTANT CAMPAIGN BY CLICKING ON THE FOLLOWING LINK:

http://ctac.ca/en/action/hep-b-c (link hosted by The Canadian Treatment Action Council)

See the full Coalition membership list here.

Hepatitis B and hepatitis C are both viruses that damage the liver, and can cause debilitating symptoms, liver disease and early death. Hepatitis B and C often go unrecognized, undiagnosed and untreated for years in those infected.  Hepatitis B and C are poorly understood with inadequately funded research, poorly supported prevention initiatives and limited access to treatment, care and support. Furthermore, stigma associated with hepatitis compounds poor health outcomes.

In Canada, both provincial and federal strategies for coordinating the research and prevention of hepatitis B and C and the care, treatment and support of people at risk of or living with hepatitis B and C have been too narrow in scope, inconsistently adopted and inadequately funded. Only recently has there been a renewed energy in different parts of Canada to refocus the response to hepatitis B and C.

The Canadian Coalition of Organizations Responding to Hepatitis B and C unites organizations and individuals to focus increased attention on the response to hepatitis B and C–diseases that negatively affect the quality of life of up to 600,000 Canadians and their families, friends, caregivers and communities.

Our goal is to see federal, provincial and territorial governments demonstrate their commitment to hepatitis B and C prevention, care, treatment, support and research with funding proportionate to the impact and burden of this health issue.

Specifically, we ask federal, provincial and territorial governments to adopt a fully funded, coordinated national strategy by 2012 that:

• Promotes prevention of both hepatitis B and C through expanded education, immunization and harm reduction programs all across Canada.
• Improves access to comprehensive care and treatment programs in all areas of the country.
• Increases knowledge and innovation through interdisciplinary research and surveillance to reduce and monitor the burden of both hepatitis B and C on Canadians.
• Creates awareness about risk factors, stigma and the need for testing among the general population and at-risk groups.
• Builds capacity through training and recruitment of qualified service providers and health professionals.
• Supports communities and community-based groups in developing, delivering and evaluating peer-driven and focused initiatives.

These “Asks” complement the six global “Asks” formulated by the World Hepatitis Alliance which are:

• Public recognition of chronic viral hepatitis as an urgent public health issue
• The appointment of an individual to lead Government strategy nationally
• The development of a patient pathway for screening, diagnosis, referral and treatment
• Clear, quantifiable targets for reducing incidence and prevalence
• Clear, quantifiable targets for reducing mortality
• Clear, quantifiable targets for screening

The Coalition is open to any organization, group or individual concerned with hepatitis B and/or hepatitis C that has formally indicated support of the Coalition’s goals. There is no fee for joining and no obligation to devote staff or financial resources. Members will be notified of Coalition goals and activities, have the opportunity to provide feedback on and contribute to those goals and activities and participate in a Coalition Steering Committee (described below).

Coalition Organizational Membership

To join as an organizational member, an organization fills out the attached membership form and acknowledges support for the goals and intent of the Coalition, and agrees to participate in the activities of the Coalition, as follows:

1. Show public support for coalition goals by appearing on a public list of Coalition members that will be shown to people including but not limited to policy makers and members of the media.
2. Periodically ask your members to act.  Ask your leaders and members to participate in occasional phone, email and mail campaigns, public events, visits or other events/activities organized by the Coalition to influence policy decisions.
3. Participate in the appointment, election or approval of Steering Committee members. All Steering Committee meetings are open to organizational members.

Organizational members will retain official voting rights, although the decision-making process is currently consensus-based.

We ask that your organization or group’s authorized decision-making body review the goals, intent and activities of the coalition and indicate agreement with them on the membership form.

Individuals Participation in the Coalition

Individuals concerned about hepatitis C and B who are not affiliated with an organization are invited to have their names included in the Coalitions email list.  They would then receive information about campaigns, opinion surveys from the Coalition, event announcements and other related information.

Future ways to participate in the Coalition could include web-based discussion forums and other ways of communicating and interacting around hepatitis B and C issues, concerns and successes.

Coalition Structure

A Coalition Steering Committee will coordinate the Coalition’s efforts and activities and keep the membership informed of the Steering Committee’s work. At this time any member can join the Steering Committee.  At such time the group becomes too large to work effectively, the Coalition will redefine its operating structure.

All members will be kept informed of the Coalition’s activities and progress.

Initial Activities (April – June 2010):

To meet the goals outlined herein, the Coalition has proposed the following short-term tasks:

• Establishing the Coalition, striking the Steering Committee and building its membership

• Promoting the 12 Asks and generating action on issues described therein

Future Activities and Roles:

To maintain momentum and further the response to hepatitis B and C in Canada, the Coalition has identified future activities and roles that may take priority:

• Setting up a website and blog as a primary communication tool, where the Coalition and its activities can be promoted and updated, and members can share experiences, successes, challenges and concerns about hepatitis-related issues.
• Acting as a hepatitis B and hepatitis C consultant group for government, government agencies, health policy makers and industry representatives.
• Acting as a forum for members to spotlight hepatitis B or C concerns or events.
• Providing collective response to issues and concerns raised by the membership.

To join or for more information, fill out the Membership Form, or contact:

Canadian Coalition of Organizations Responding to Hepatitis B and C

c/o   Deb Schmitz, Hepatitis C Council of BC. PHONE: 604 886 9539  FAX: 1 888 856 5882

E-mail: canadahepbccoalition@gmail.com

For media inquiries, please go to the Coalition Members page and directly contact the group (or groups) which interest you.